Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. This book presents the summary of a workshop convened to address the current status of drug-resistant TB globally and in China.
Sharing Clinical Research Data: Workshop Summary
Differences between children and adults in the overall response to medications are due to profound anatomical, physiological, and developmental differences. This book identifies barriers to the development and testing of drugs for pediatric populations, and ways in which the system can be improved to facilitate better treatments for children.
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.
